Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine

NCT04921384 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

981

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Placebo
DRUG: Eptinezumab

Sponsor

H. Lundbeck A/S